Kite Pharma, Inc.: cashflow_operating
| Value | {"amount": -29168000, "concept": "us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "currency": "USD"} |
|---|---|
| Period | 2016-01-01 – 2016-03-31 |
| Status | current |
| Entity | Kite Pharma, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T15:09:21.819924+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/8aa9af49-120d-47a0-932e-e30e473d8d09
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001510580-17-000006 · Open the official SEC filing →Retrieved: 2026-08-19T15:09:21.819924+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001510580/cashflow-operating/2016-03-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/8aa9af49-120d-47a0-932e-e30e473d8d09
History
- supersedes {"amount": -28688000, "concept": "us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "currency": "USD"} (evidence 0001564590-16-018576)